Čájehuvvojit
1 - 5
oktiibuot
5
bohtosis ohcui
Shengchao Huang (22686392)
'
Sirdás sisdollui
VuFind
Čálihuva
Giella
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Buot deaivamat
Bajilčálus
Dahkki
Fáddá
Hildobáiki
ISBN/ISSN
Fáddágilkor
Viečča
Aiddostahtton
Dahkki
Shengchao Huang (22686392)
Čájehuvvojit
1 - 5
oktiibuot
5
bohtosis ohcui
Shengchao Huang (22686392)
'
, ohcanáigi: 0,01s
Aiddostahte ozu
Ordne
Relevánsa
Jahki (vuohččan ođđaseamos)
Jahki (vuohččan boarráseamos)
Luohkká
Dahkki
Bajilčálus
1
Table 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.docx
Dahkki
Huijie Deng (5664421)
Almmustuhtton 2025
Eará dahkkit:
Lasit oiddohiidda
Furkejuvvon:
2
Table 1_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.docx
Dahkki
Huijie Deng (5664421)
Almmustuhtton 2025
Eará dahkkit:
Lasit oiddohiidda
Furkejuvvon:
3
Image 1_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif
Dahkki
Huijie Deng (5664421)
Almmustuhtton 2025
Eará dahkkit:
Lasit oiddohiidda
Furkejuvvon:
4
Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif
Dahkki
Huijie Deng (5664421)
Almmustuhtton 2025
Eará dahkkit:
Lasit oiddohiidda
Furkejuvvon:
5
Table 3_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.docx
Dahkki
Huijie Deng (5664421)
Almmustuhtton 2025
Eará dahkkit:
Lasit oiddohiidda
Furkejuvvon:
Ohcanreaiddut:
RSS-biepmus
Sádde ozu šleađgaboasttain